Entering text into the input field will update the search result below

cbdMD initiates clinical study exploring cannabinoid blend in humans

Dec. 03, 2021 9:35 AM ETcbdMD, Inc. (YCBD)By: SA News Team
  • cbdMD (YCBD +0.7%) has commenced a preclinical human study with researchers at the University of South Carolina.
  • The study will explore the effects of cbdMD’s proprietary broad spectrum cannabinoid blend on sleep, mood, and pain in healthy subjects to further support the

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.